Adequate vascular access is of paramount importance in oncology patients. It is important in
the initial phase of surgical treatment or chemotherapy, as well as in the chronic …

Background and objectives: The increasing use of arm totally implantable vascular access
devices for breast cancer patients who require chemotherapy has led to a greater risk of …

The first placement of a totally implantable central venous access device (TIVAD) was
performed in 1982 at the MD Anderson Cancer Center in Houston by John Niederhuber …

PURPOSE We undertook this study to review our experience with indwelling vascular
access devices in cancer patients to identify factors associated with complications …

Abstract Background and Objectives Vascular access has great importance in the treatment
of patients submitted to prolonged chemotherapy. Purpose of this study is to assess the …

Venous access has been a problem for the practicing oncologist. Previous approaches,
such as arteriovenous fistulas, grafts, or percutaneous catheters, have not gained …

Background Central venous access is extensively used in oncology, though practical
information from randomized trials on the most convenient insertion modality and site is …

Vascular access technology is rapidly improving. Over the last 7 years we evaluated 826
access devices in 681 patients with neoplastic disease. The devices included 103 …

This guideline applies to central venous access in adult cancer patients, which includes
peripherally inserted central catheters (PICCs), tunnelled central catheters and totally …

Aims The use of subcutaneous infusion ports has become standard practice to provide a
long-term venous access in oncological patients. The aim of this retrospective study was to …